Navigation Links
Significant Rise in Proportion of Chronically Ill Children Dying in Intensive Care

The proportion of chronically ill young children dying in intensive care after being admitted to other hospital wards has steadily risen year on year since the end of the 1990s,// reveals a study in the Journal of Medical Ethics.

The researchers analysed the records of one large children’s hospital, to find out where children had died, and of what causes.

The period of analysis spanned seven years from 1997 to 2004 and included all age groups from 0 to 18 years.

During the seven years, 1127 children died, over half of whom (58%) were younger than 12 months.

Congenital malformations, perinatal disease, cardiovascular disorders, and cancers formed the bulk of the causes of death.

There were no major changes to overall admission rates to the hospital or to intensive care over the study period, nor did overall death rates vary.

But the numbers of children dying in intensive care rose from around 80% in 1997 to almost 91% in 2004.

Among children who died in intensive care, the numbers of those who had been admitted from wards within the hospital almost doubled over the same period from just under 15% to 25%.

Children spent almost two weeks elsewhere before admission to intensive care.

Infants with congenital problems or perinatal disease were more than twice as likely to die in intensive care, while older children with cancer were more than six times as likely to die in other hospital wards.

The authors say that guidance from the Royal College of Paediatrics and Child Health, published in 1997, specifies what sorts of conditions merit withdrawing of life support or active treatment.

But the rising numbers of children dying in intensive care suggests that it is not being followed and that terminally ill children are still being actively treated.

This might be because the course of acute bouts of illness in children with
'"/>




Page: 1 2

Related medicine news :

1. Inhaled Corticosteroids Found To Have No Significant Effect On COPD
2. A Little Weight Loss Found To Make A Significant Difference In Men
3. New Drug Shows Significant Improvement In HIV-related Heart Condition
4. Patient Negligence - Significant Problem In The Early Detection Of Breast Cancer
5. Kidney Disease, More Significant Risk Factor For Heart Disease Than Obesity
6. Silicone Implants Make No Significant Difference To Breast Cancer Survivors
7. Biomarkers Could Prove Significant In Understanding Aging Process
8. Smoke From Cooking Fuels Cause A Significant Number Of Death Worldwide
9. Increased Nighttime BP, a Significant Predictor of Congestive Heart Failure
10. Significant Advance in Treatment of Breast Cancer Reported
11. Significant role of genetics in drug abuse, Norwegian study
Post Your Comments:
(Date:8/28/2014)... August 28, 2014 Save On ... tech accelerator program in Tampa. Healthbox Florida has ... healthcare companies grow and achieve their goals. , ... 16th, at their launch event at the Mahaffey Theater ... , Co-founder Matt Schneider commented on the Save On ...
(Date:8/28/2014)... Commercial growers all over the continent are waitlisted to ... lights, which perform on par with 1000w HPS at 65% ... needs no cooling equipment and does not overheat the space, ... in that they never need bulbs changed, the internal ROI ... , For many indoor growers, cooler room temperatures also has ...
(Date:8/28/2014)... candidate Ebola vaccine could be given to healthy volunteers ... as September, as part of an series of safety ... that has killed more than 1,400 people in the ... this candidate vaccine, being co-developed by the US National ... accelerated with funding from an international consortium in response ...
(Date:8/28/2014)... repairing nerves with adhesives, most researchers place glue directly ... fix the nerve ends well and allows glue to ... cylindrical. However, it is difficult to insert the nerve ... and there is frictional resistance. Xiangdang Liang and co-workers ... special conduit for the adhesive technique and defined the ...
(Date:8/28/2014)... (Aug. 28, 2014) A subset of patients with ... treated with irinotecan-based therapy, according to a new study ... official journal of the American Gastroenterological Association. , When ... leucovorin adjuvant irinotecan therapy improved overall survival rates ... CIMP is seen in about 10 to 20 percent ...
Breaking Medicine News(10 mins):Health News:Save On Medical Accepted Into Healthbox Accelerator Program 2Health News:New Kind K5 Series LED Grow Lights Pave Way for Future of Indoor Gardening 2Health News:Ebola vaccine trials fast-tracked by international consortium 2Health News:Ebola vaccine trials fast-tracked by international consortium 3Health News:Ebola vaccine trials fast-tracked by international consortium 4Health News:Drug shows promise for subset of stage III colon cancer patients 2
... using small impulses of electricity. This innovative device is ... // (TENS) technology, which has long been used by ... pain. ,The device comes in the form of a ... in the air from the snoring sound. ,Sensors ...
... scientists have developed a test that can detect the Hepatitis ... by Arieh Yaari of Soroka University Medical Centre // ... people without kidney functions whose blood must be passed through ... SciDev Net. ,Such patients have a high incidence of ...
... British Cardiac Society, the British Hypertension Society, Diabetes ... // and the Stroke Association have collaboratively ... attacks, stroke and hardening of leg arteries. The ... of developing heart attacks by properly maintaining one’s ...
... cannot be cured by taking medications reports a study ... review of eight // clinical trials that complementary and ... occur after alcohol consumption. Some of the common hangover ... diarrhea, dizziness, fatigue, depressed, poor memory. ,Though, ...
... Health experts in the United States fear that if the deadly ... risk since they are vulnerable // to the H5N1 virus. ... 70 lives in Asia and has appeared in parts of Europe ... slaughtered in an effort to contain the virus. However, experts fear ...
... study conducted at Oregon Health & Science University and ... that a perfect molecular mixture present in male-emitted pheromone ... and increased aggression) dictates the sexual behavior of other ... interest. ,The researchers argue that release of ...
Cached Medicine News:Health News:The Chemistry Of Sexual Attraction Between Male And Female Elephants 2
(Date:8/28/2014)... , August 28, 2014 ... Market Research "Radiofrequency Identification (RFID) Market (Tags, Readers, Middleware, ... Growth, Trends and Forecast, 2014 - 2020" the global ... billion in 2013 and is expected to grow at ... reach an estimated value of USD 5.3 billion in ...
(Date:8/28/2014)... 28, 2014   Venaxis, Inc.  (Nasdaq:  APPY), an ... FDA clearance for and commercializing its CE Marked ... in identifying children, adolescent, and young adult patients in ... appendicitis, today announced it will present at three upcoming ... Annual Global Investment Conference being held in ...
(Date:8/28/2014)... 2014 Telik, Inc. (OTCQB: TELK), a ... with MabVax Therapeutics, Inc. on July 8, 2014, ... to the development of its lead antibody program ... the Company,s internally developed antibody discovery platform.  These ... antibody based therapeutic and diagnostic products based on ...
Breaking Medicine Technology:Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 2Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 3Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 4Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 5Venaxis to Present at September Investor Conferences 2Venaxis to Present at September Investor Conferences 3Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 2Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 3Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 4
... traits contribute to risk, of skin cancer; findings will ... May 18 In two papers published,today, deCODE scientists ... the company,s recent findings in the genetics of pigmentation,traits ... of these,common variants also confer risk of two types ...
... Annual Meeting Will Further Demonstrate, the Strength ... CAMBRIDGE, Mass., May 16 Millennium Pharmaceuticals,The Takeda Oncology ... are scheduled to be featured at the 2008 American ... May 30 -,June 3, 2008. The data will highlight ...
Cached Medicine Technology:deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 2deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 3deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 4New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 2New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 3New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 4New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 5New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 6New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 7New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 8
The EZY Close post op shoe's flap-on-flap closure provides a secure fit and can accommodate even the bulkiest of dressing. Perfect for older patients with limited hand dexterity....
This popular post op shoe provides quality care at an outstanding value. The semi-rigid outsole provides stability and minimizes flexure....
... who experience severe plantar fasciitis pain, the ... fibrous tissue that can occur after rest ... in the morning. The continuous tension and ... plantar fasciitis and helps stretch the Achilles ...
... Bird and Cronin, ... manufacturer of Patient Footwear, ... Patient Care Products. Our ... highest quality and available ...
Medicine Products: